SCHEMBL8949636

SCHEMBL8949636

CNc1ccccc1.O=P(O)(O)P(=O)(O)C(F)(F)F

nearest known ligand 0.50

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
TSHR P16473 1/20 0.50
PTPN1 P18031 2/20 0.41
CA12 O43570 1/20 0.39
CA9 Q16790 1/20 0.39
PDK1 Q15118 2/20 0.38
PDK2 Q15119 2/20 0.38
PDK3 Q15120 2/20 0.38
PDK4 Q16654 2/20 0.38
PTPN5 P54829 2/20 0.37
PGK1 P00558 4/20 0.35
PGK2 P07205 4/20 0.35
KIF11 P52732 1/20 0.35
NAPRT Q6XQN6 1/20 0.34
HSD17B10 Q99714 1/20 0.34
NPC1 O15118 1/20 0.34
RAB9A P51151 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8949885 0.79 TSHR (0.61) TSHRCA12CA9NAPRTHSD17B10
Methyl Phosphonate SCHEMBL9136984 0.78 TSHR (0.67) TSHRCA12CA9NAPRTHSD17B10
Methyl Phosphonate SCHEMBL9137329 0.77 TSHR (0.64) TSHRCA12CA9NAPRTHSD17B10
Trifluoroacetic Acid SCHEMBL584478 0.75 TSHR (0.61) TSHRPDK1PDK2PDK3PDK4
Trifluoroacetic Acid SCHEMBL9333894 0.75 TSHR (0.61) TSHRPDK1PDK2PDK3PDK4
Trifluoromethanesulfonic Acid SCHEMBL1934271 0.72 TSHR (0.56) TSHRPTPN1CA12PDK1PDK2
Methyl Alcohol SCHEMBL11681702 0.71 TSHR (0.88) TSHRNAPRTHSD17B10
SCHEMBL4454 0.71
SCHEMBL3008675 0.71
SCHEMBL8949864 0.71 PGK1 (0.38) PTPN1PGK1PGK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5574024-A Methylene phosphonoalkylphosphinates, pharmaceutical compositions, and methods for treating abnormal calcium and phosphate metabolism EBETINO FRANK H (US) 1996-11-12 US disclosed
EP-0298553-B1 METHYLENE PHOSPHONOALKYLPHOSPHINATES, PHARMACEUTICAL COMPOSITIONS, AND METHODS FOR TREATING ABNORMAL CALCIUM AND PHOSPHATE METABOLISM Norwich Eaton Pharmaceuticals, Inc. (US) 1992-01-15 EP disclosed